These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16969897)

  • 1. [Pharmacological treatment of vascular cognitive impairment].
    Bidzan L
    Przegl Lek; 2006; 63(3):131-3. PubMed ID: 16969897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
    Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
    J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.
    Moretti R; Torre P; Antonello RM; Cazzato G; Pizzolato G
    Am J Alzheimers Dis Other Demen; 2008; 23(2):167-76. PubMed ID: 18184948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern therapy for dementia].
    Padberg F; Möller HJ; Bottlender R; Hampel H
    MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2010 Mar; 8(91):19-24. PubMed ID: 20179667
    [No Abstract]   [Full Text] [Related]  

  • 6. Dementia.
    Warner J; Butler R; Arya P
    Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
    [No Abstract]   [Full Text] [Related]  

  • 7. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
    Rojas-Fernandez CH; Moorhouse P
    Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine for vascular cognitive impairment.
    Craig D; Birks J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004744. PubMed ID: 15846730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular dementia and vascular cognitive impairment].
    Qian CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):198-200. PubMed ID: 15171562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of mild cognitive impairment: value of citicoline].
    Abad-Santos F; Novalbos-Reina J; Gallego-Sandín S; García AG
    Rev Neurol; 2002 Oct 1-15; 35(7):675-82. PubMed ID: 12389156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ginkgo Biloba as a cognitive enhancer].
    Arushanian EB; Beĭer EV
    Eksp Klin Farmakol; 2008; 71(4):57-63. PubMed ID: 18819443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing practice with cognition enhancers in outpatient care: are there differences regarding type of dementia?--Results of a representative survey in lower Saxony, Germany.
    Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E
    Pharmacopsychiatry; 1996 Jul; 29(4):150-5. PubMed ID: 8858714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational treatment for vascular cognitive impairment.
    Birks J; Flicker L
    Expert Opin Investig Drugs; 2007 May; 16(5):647-58. PubMed ID: 17461738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of a traditional ginkgo fresh plant extract - results from a clinical trial.
    Bäurle P; Suter A; Wormstall H
    Forsch Komplementmed; 2009 Jun; 16(3):156-61. PubMed ID: 19657199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimodipine in subcortical vascular dementia trial.
    Rossi R; Inzitari D; Pantoni L; del Ser T; Erkinjuntti T; Wallin A; Bianchi C; Badenas JM; Beneke M
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S159-65. PubMed ID: 10609696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular cognitive deterioration and stroke.
    Erkinjuntti T
    Cerebrovasc Dis; 2007; 24 Suppl 1():189-94. PubMed ID: 17971655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicardipine use in cerebrovascular disease: a review of controlled clinical studies.
    Amenta F; Lanari A; Mignini F; Silvestrelli G; Traini E; Tomassoni D
    J Neurol Sci; 2009 Aug; 283(1-2):219-23. PubMed ID: 19303080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of vascular dementia and vascular cognitive impairment.
    Demaerschalk BM; Wingerchuk DM
    Neurologist; 2007 Jan; 13(1):37-41. PubMed ID: 17215726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
    Kidd PM
    Altern Med Rev; 1999 Jun; 4(3):144-61. PubMed ID: 10383479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.
    Pantoni L; Carosi M; Amigoni S; Mascalchi M; Inzitari D
    Clin Neuropharmacol; 1996 Dec; 19(6):497-506. PubMed ID: 8937788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.